Institute for Neurophysiology, University of Cologne, Cologne, Germany.
PLoS One. 2013 Aug 2;8(8):e70913. doi: 10.1371/journal.pone.0070913. Print 2013.
Catecholamine release is known to modulate cardiac output by increasing heart rate. Although much is known about catecholamine function and regulation in adults, little is known about the presence and role of catecholamines during heart development. The present study aimed therefore to evaluate the effects of different catecholamines on early heart development in an in vitro setting using embryonic stem (ES) cell-derived cardiomyocytes. Effects of catecholamine depletion induced by reserpine were examined in murine ES cells (line D3, αPIG44) during differentiation. Cardiac differentiation was assessed by immunocytochemistry, qRT-PCR, quantification of beating clusters, flow cytometry and pharmacological approaches. Proliferation was analyzed by EB cross-section measurements, while functionality of cardiomyocytes was studied by extracellular field potential (FP) measurements using microelectrode arrays (MEAs). To further differentiate between substance-specific effects of reserpine and catecholamine action via α- and β-receptors we proved the involvement of adrenergic receptors by application of unspecific α- and β-receptor antagonists. Reserpine treatment led to remarkable down-regulation of cardiac-specific genes, proteins and mesodermal marker genes. In more detail, the average ratio of ∼40% spontaneously beating control clusters was significantly reduced by 100%, 91.1% and 20.0% on days 10, 12, and 14, respectively. Flow cytometry revealed a significant reduction (by 71.6%, n = 11) of eGFP positive CMs after reserpine treatment. By contrast, reserpine did not reduce EB growth while number of neuronal cells in reserpine-treated EBs was significantly increased. MEA measurements of reserpine-treated EBs showed lower FP frequencies and weak responsiveness to adrenergic and muscarinic stimulation. Interestingly we found that developmental inhibition after α- and β-adrenergic blocker application mimicked developmental changes with reserpine. Using several methodological approaches our data suggest that reserpine inhibits cardiac differentiation. Thus catecholamines play a critical role during development.
儿茶酚胺的释放已知通过增加心率来调节心输出量。尽管人们对成人儿茶酚胺的功能和调节有很多了解,但对心脏发育过程中儿茶酚胺的存在和作用知之甚少。因此,本研究旨在评估儿茶酚胺在体外环境下对胚胎干细胞(ES)细胞衍生的心肌细胞早期心脏发育的影响。通过用利血平诱导儿茶酚胺耗竭来检测鼠 ES 细胞(D3 细胞系,αPIG44)在分化过程中的作用。通过免疫细胞化学、qRT-PCR、跳动细胞簇的定量、流式细胞术和药理学方法评估心脏分化。通过 EB 横截面测量分析增殖,通过微电极阵列(MEA)的细胞外场电位(FP)测量研究心肌细胞的功能。为了进一步区分利血平和儿茶酚胺通过α-和β-受体作用的物质特异性效应,我们通过应用非特异性α-和β-受体拮抗剂来证明肾上腺素能受体的参与。利血平处理导致心脏特异性基因、蛋白质和中胚层标记基因的显著下调。更详细地说,在第 10、12 和 14 天,平均自发跳动对照簇的比例分别显著降低至 40%,91.1%和 20.0%。流式细胞术显示利血平处理后 eGFP 阳性 CM 的数量显著减少(减少 71.6%,n = 11)。相比之下,利血平并没有减少 EB 的生长,而利血平处理的 EB 中的神经元细胞数量明显增加。MEA 测量利血平处理的 EB 显示 FP 频率较低,对肾上腺素能和毒蕈碱刺激的反应较弱。有趣的是,我们发现α-和β-肾上腺素能阻滞剂应用后的发育抑制模仿了利血平的发育变化。使用几种方法学方法,我们的数据表明利血平抑制心脏分化。因此,儿茶酚胺在发育过程中起着关键作用。